Kanghong Pharmaceutical's stock option plan enters exercise period

Chengdu Kanghong Pharmaceutical Group's 2021 stock option incentive plan has reached its third exercise period for the reserved grant portion. Two eligible employees can exercise 35,400 stock options at an exercise price of CNY 13.84 per share. This follows a dividend distribution on June 6, 2025, which adjusted the exercise price from CNY 14.44.

The company has also approved the cancellation of 524,300 unexercised stock options due to various reasons, including 2024 performance targets not being met and expired exercise periods. This cancellation includes 31 individuals from the reserved grant portion and 13 employees from the initial grant who departed or did not meet performance metrics in 2024. The total share capital will increase by 1,521,700 shares due to option exercises.

The board confirmed that the exercise conditions are met and the cancellations comply with regulations, without negatively impacting the company's financial health or management stability. The options will be open for exercise between July 11, 2025, and July 10, 2026.